Acupuncture Doesn't Up Live Birth Rate for Women Having IVF

Share this content:
Acupuncture Doesn't Up Live Birth Rate for Women Having IVF
Acupuncture Doesn't Up Live Birth Rate for Women Having IVF

TUESDAY, May 15, 2018 (HealthDay News) -- For women undergoing in vitro fertilization (IVF), acupuncture at the time of ovarian stimulation and embryo transfer is not associated with a significant difference in live birth rate compared with sham acupuncture, according to a study published in the May 15 issue of the Journal of the American Medical Association.

Caroline A. Smith, Ph.D., from Western Sydney University, and colleagues conducted a randomized clinical trial involving 848 women undergoing a fresh IVF cycle conducted at 16 IVF centers in Australia and New Zealand. Women were randomly allocated to receive acupuncture or a sham acupuncture control in a 1:1 ratio. Treatments were administered between days six to eight of follicle stimulation, and prior to and following embryo transfer.

Data on live birth outcomes were available for 809 women. The researchers found that live births occurred in 18.3 and 17.8 percent of women receiving acupuncture and sham control, respectively (risk difference, 0.5 percent [95 percent confidence interval, −4.9 to 5.8 percent]; relative risk, 1.02 [95 percent confidence interval, 0.76 to 1.38]).

"Among women undergoing IVF, administration of acupuncture versus sham acupuncture at the time of ovarian stimulation and embryo transfer resulted in no significant difference in live birth rates," the authors write. "These findings do not support the use of acupuncture to improve the rate of live births among women undergoing IVF."

One author disclosed financial ties to the pharmaceutical industry; several authors disclosed ties to fertility clinics and a fertility company.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Customizable Insulin Pump

FDA Approves First Customizable Insulin Pump

Product works by delivering insulin under the skin at set or variable rates

Sepsis Common in Terminal Hospitalizations, Discharges

Sepsis Common in Terminal Hospitalizations, Discharges

Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer older men than women, even with higher risk, undergo DXA screening, 25(OH)D measurement

is free, fast, and customized just for you!




Already a member?

Sign In Now »